Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale: Correlates with echo-doppler assessment

E. Clini, G. Cremona, M. Campana, C. Scotti, M. Pagani, L. Bianchi, A. Giordano, N. Ambrosino

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Exhaled nitric oxide (NO) production in stable chronic obstructive pulmonary disease (COPD) has been loosely related to the severity of illness, being significantly reduced in the most severe cases. Pulmonary hypertension is associated with lower NO output from the lung. In this study expired NO was measured in patients with severe stable COPD with or without cot pulmonale (CP). Echocardiographic estimates of right heart function, lung function, diffusion capacity, respiratory muscle strength, and arterial blood gases were obtained in 34 consecutive patients with stable COPD (mean age, 68 ± 7 yr). Expired NO was measured by chemiluminiscence to obtain fractional exhaled concentrations at peak (FENOp) and at plateau (FENOpl) points of the single-breath curve and resting NO output (VNO). All measurements of expired NO output, FENOp, FENOpl and VNO showed a negative correlation with both systolic pulmonary artery pressure (Pspa) (r = -0.51, -0.63, and -0.63, respectively, p <0.01 for all) and right ventricle wall dimension (r = -0.41, -0.59, and -0.43, respectively, p <0.05 for all), but not with any measurement of lung function. When the patients were divided according to the Pspa using a cutoff limit of 35 mm Hg, those subjects with CP showed lower FENOp (13.2 ± 4.0 versus 36.7 ± 30.8 ppb, p <0.05), FENOpl (5.7± 1.9 versus 8.9 ± 4.7 ppb, p <0.05), and VNO (69.2 ± 5.6 versus 107.6 ± 14.6 nl/min, p = 0.02) than did those with a normal resting Pspa. NO production from the airways was significantly lower and inversely related to development of CP in patients with severe COPD. Impaired endothelial release may account for the reduced levels of expired NO.

Original languageEnglish
Pages (from-to)446-450
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume162
Issue number2 I
Publication statusPublished - 2000

Fingerprint

Pulmonary Heart Disease
Chronic Obstructive Pulmonary Disease
Nitric Oxide
Lung
Respiratory Muscles
Muscle Strength
Pulmonary Hypertension
Pulmonary Artery
Heart Ventricles
Gases
Pressure

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale : Correlates with echo-doppler assessment. / Clini, E.; Cremona, G.; Campana, M.; Scotti, C.; Pagani, M.; Bianchi, L.; Giordano, A.; Ambrosino, N.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 162, No. 2 I, 2000, p. 446-450.

Research output: Contribution to journalArticle

@article{cc2cdcb9e38146bbafcc139ab63eece3,
title = "Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale: Correlates with echo-doppler assessment",
abstract = "Exhaled nitric oxide (NO) production in stable chronic obstructive pulmonary disease (COPD) has been loosely related to the severity of illness, being significantly reduced in the most severe cases. Pulmonary hypertension is associated with lower NO output from the lung. In this study expired NO was measured in patients with severe stable COPD with or without cot pulmonale (CP). Echocardiographic estimates of right heart function, lung function, diffusion capacity, respiratory muscle strength, and arterial blood gases were obtained in 34 consecutive patients with stable COPD (mean age, 68 ± 7 yr). Expired NO was measured by chemiluminiscence to obtain fractional exhaled concentrations at peak (FENOp) and at plateau (FENOpl) points of the single-breath curve and resting NO output (VNO). All measurements of expired NO output, FENOp, FENOpl and VNO showed a negative correlation with both systolic pulmonary artery pressure (Pspa) (r = -0.51, -0.63, and -0.63, respectively, p <0.01 for all) and right ventricle wall dimension (r = -0.41, -0.59, and -0.43, respectively, p <0.05 for all), but not with any measurement of lung function. When the patients were divided according to the Pspa using a cutoff limit of 35 mm Hg, those subjects with CP showed lower FENOp (13.2 ± 4.0 versus 36.7 ± 30.8 ppb, p <0.05), FENOpl (5.7± 1.9 versus 8.9 ± 4.7 ppb, p <0.05), and VNO (69.2 ± 5.6 versus 107.6 ± 14.6 nl/min, p = 0.02) than did those with a normal resting Pspa. NO production from the airways was significantly lower and inversely related to development of CP in patients with severe COPD. Impaired endothelial release may account for the reduced levels of expired NO.",
author = "E. Clini and G. Cremona and M. Campana and C. Scotti and M. Pagani and L. Bianchi and A. Giordano and N. Ambrosino",
year = "2000",
language = "English",
volume = "162",
pages = "446--450",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society - AJRCCM",
number = "2 I",

}

TY - JOUR

T1 - Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale

T2 - Correlates with echo-doppler assessment

AU - Clini, E.

AU - Cremona, G.

AU - Campana, M.

AU - Scotti, C.

AU - Pagani, M.

AU - Bianchi, L.

AU - Giordano, A.

AU - Ambrosino, N.

PY - 2000

Y1 - 2000

N2 - Exhaled nitric oxide (NO) production in stable chronic obstructive pulmonary disease (COPD) has been loosely related to the severity of illness, being significantly reduced in the most severe cases. Pulmonary hypertension is associated with lower NO output from the lung. In this study expired NO was measured in patients with severe stable COPD with or without cot pulmonale (CP). Echocardiographic estimates of right heart function, lung function, diffusion capacity, respiratory muscle strength, and arterial blood gases were obtained in 34 consecutive patients with stable COPD (mean age, 68 ± 7 yr). Expired NO was measured by chemiluminiscence to obtain fractional exhaled concentrations at peak (FENOp) and at plateau (FENOpl) points of the single-breath curve and resting NO output (VNO). All measurements of expired NO output, FENOp, FENOpl and VNO showed a negative correlation with both systolic pulmonary artery pressure (Pspa) (r = -0.51, -0.63, and -0.63, respectively, p <0.01 for all) and right ventricle wall dimension (r = -0.41, -0.59, and -0.43, respectively, p <0.05 for all), but not with any measurement of lung function. When the patients were divided according to the Pspa using a cutoff limit of 35 mm Hg, those subjects with CP showed lower FENOp (13.2 ± 4.0 versus 36.7 ± 30.8 ppb, p <0.05), FENOpl (5.7± 1.9 versus 8.9 ± 4.7 ppb, p <0.05), and VNO (69.2 ± 5.6 versus 107.6 ± 14.6 nl/min, p = 0.02) than did those with a normal resting Pspa. NO production from the airways was significantly lower and inversely related to development of CP in patients with severe COPD. Impaired endothelial release may account for the reduced levels of expired NO.

AB - Exhaled nitric oxide (NO) production in stable chronic obstructive pulmonary disease (COPD) has been loosely related to the severity of illness, being significantly reduced in the most severe cases. Pulmonary hypertension is associated with lower NO output from the lung. In this study expired NO was measured in patients with severe stable COPD with or without cot pulmonale (CP). Echocardiographic estimates of right heart function, lung function, diffusion capacity, respiratory muscle strength, and arterial blood gases were obtained in 34 consecutive patients with stable COPD (mean age, 68 ± 7 yr). Expired NO was measured by chemiluminiscence to obtain fractional exhaled concentrations at peak (FENOp) and at plateau (FENOpl) points of the single-breath curve and resting NO output (VNO). All measurements of expired NO output, FENOp, FENOpl and VNO showed a negative correlation with both systolic pulmonary artery pressure (Pspa) (r = -0.51, -0.63, and -0.63, respectively, p <0.01 for all) and right ventricle wall dimension (r = -0.41, -0.59, and -0.43, respectively, p <0.05 for all), but not with any measurement of lung function. When the patients were divided according to the Pspa using a cutoff limit of 35 mm Hg, those subjects with CP showed lower FENOp (13.2 ± 4.0 versus 36.7 ± 30.8 ppb, p <0.05), FENOpl (5.7± 1.9 versus 8.9 ± 4.7 ppb, p <0.05), and VNO (69.2 ± 5.6 versus 107.6 ± 14.6 nl/min, p = 0.02) than did those with a normal resting Pspa. NO production from the airways was significantly lower and inversely related to development of CP in patients with severe COPD. Impaired endothelial release may account for the reduced levels of expired NO.

UR - http://www.scopus.com/inward/record.url?scp=0033841145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033841145&partnerID=8YFLogxK

M3 - Article

C2 - 10934068

AN - SCOPUS:0033841145

VL - 162

SP - 446

EP - 450

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2 I

ER -